T. Patrick Hill

T. Patrick Hill

Associate Teaching Professor, Emeritus
B.A./M.A. University of Cambridge, England; M.A. University of California, Los Angeles; Ph.D. University of Chicago  
  • tpatri [at] rutgers.edu
Research Interests
  • Ethics and science/technology
  • Clinical research
  • Neonatology

T. Patrick Hill, Ph.D. is an Associate Teaching Professor, Emeritus at the Edward J. Bloustein School of Planning and Public Policy, Rutgers University, where he taught courses in Public Health Law and Ethics, Ethics for Planning and Public Policy, and Writing, Reasoning and Public Policy. Dr. Hill is also clinical ethics consultant to the Neonatology Division at Robert Wood Johnson University Medical Center. He is a member of the Newborn Screening Review Committee for the New Jersey Department of Health and Senior Services. He has served as ethics consultant to The Cancer Institute of New Jersey, The Translational Research Working Group, The National Cancer Institute, Washington,D.C., The IRB Executive Committee, The University of Medicine and Dentistry, New Jersey, and the Religious Coalition for Reproductive Choice, Washington, D.C.  Dr. Hill is a graduate of the Pontifical Lateran University, Rome, Italy, Cambridge University, Cambridge, England, the University of California, Los Angeles, and the University of Chicago, where he earned his doctorate. Among his more recent publications are: Phase 0 Trials: Are they ethically challenged? Rare Tumors: An Appeal for Justice; Clinical Research Face to Face with Its Own Ethical Implications; Theologians on Science and Reductionism; The Moral World of Lisbeth Salander; Phase 0 Trials: Towards A More Complete Ethics Critique; Risk Assessment in Clinical Trials: It don’t mean an ethical thing if it ain’t got that probability ring.

View all course offerings and related syllabi
  • Public Health Law and Ethics
  • Writing/Reasoning/Public Policy
  • Ethics in Planning and Policy
  • Ethics in Planning & Policy

Selected Publications


  • 1992: Hill, T.Patrick, Shirley, David. A Good Death: Taking More Control at the End of Your Life. Reading, MA.: Addison-Wesley, 1992

Chapters in Books or Monographs

  • 2017: Hill, T. Patrick. “Ethical, Legal and Social Implications of Gene Editing.” in Gene Editing 101, Edited by Frances Addison. London: Front Line Genomics 2017
  • 2014: Hill, T. Patrick. “Ethical Issues in the Use of Fluids and Nutrition: When Can They Be Withdrawn?” in Health Care Ethics: Critical Issues for the 21st Century (third edition), edited by Eileen E. Morrison ad Beth Furlong. Burlington, MA: Jones and Bartlett Learning, 2014
  • 2008: Hill, T. Patrick. “Ethical Issues in the Use of Fluids and Nutrition: When Can They Be Withdrawn?” in Health Care Ethics: Critical Issues for the 21st Century (second edition), edited by Eileen E. Morrison. Sudbury, MA: Jones and Bartlett Publishers, 2008

Articles in Refereed Journals

  • 2014: Hill, T. Patrick “Risk Assessment in Clinical Trials’ ecancermedicalscience (European Institute for Oncology, Milan, Italy) Accepted for
  • 2007: Hill, T. Patrick. “Phase 0 Trials: Are They Ethically Challenged?” Clin Can Res. 2007; 13: 783-784

Articles in Non-refereed or General Journals

  • 2010: Hill, T. Patrick. “Clinical Research Face to Face with Its Own Ethical Implications”. Rutgers J of Bioethics, Vol. 1, Issue 11, 2010-20; 4-611

Electronic Publications, Refereed

  • 2012: Hill. T. Patrick. “Conducting Phase IV Clinical Studies: A Moral Imperative?”Ecancermedical sciences. DOI: 10.3332/ecancer.2012.276
  • 2012: Hill, T.Patrick. “Phase 0 Clinical Trials: Towards a More Complete Ethics Critique.” ecancermedical sciences. DOI: 10.3332/ecancer.2012.248
  • 2010: Hill, T.Patrick. “Rare Tumors: An Appeal for Justice.” The Open Clinical Cancer Journal, 2010,4, 00-00

Electronic Publications, Not Refereed

Areas of Expertise:   EthicsHealth PolicyMedical EthicsPublic HealthScience & Technology PolicySocial Policy/Inequality and Disparities